INTEC PHARMA LTD JERUSALEM's ticker is and the CUSIP is M53644106. A total of 26 filers reported holding INTEC PHARMA LTD JERUSALEM in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,000 | +33.3% | 14,733 | +34.5% | 0.00% | – |
| Q2 2020 | $3,000 | -66.7% | 10,952 | -75.3% | 0.00% | – |
| Q1 2020 | $9,000 | +125.0% | 44,263 | +478.0% | 0.00% | – |
| Q4 2019 | $4,000 | -66.7% | 7,658 | -53.0% | 0.00% | – |
| Q3 2019 | $12,000 | -96.6% | 16,285 | -80.1% | 0.00% | – |
| Q2 2019 | $356,000 | -18.0% | 81,931 | +38.4% | 0.00% | – |
| Q1 2019 | $434,000 | +81.6% | 59,216 | +87.1% | 0.00% | – |
| Q4 2018 | $239,000 | +13.8% | 31,648 | -14.9% | 0.00% | – |
| Q3 2018 | $210,000 | +32.9% | 37,183 | +3.9% | 0.00% | – |
| Q2 2018 | $158,000 | -16.4% | 35,780 | +16.2% | 0.00% | – |
| Q1 2018 | $189,000 | +4625.0% | 30,786 | +7596.5% | 0.00% | – |
| Q3 2017 | $4,000 | – | 400 | +2005.3% | 0.00% | – |
| Q1 2016 | $0 | – | 19 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 809,804 | $4,140,000 | 0.60% |
| SABBY MANAGEMENT, LLC | 514,878 | $2,652,000 | 0.14% |
| Migdal Insurance & Financial Holdings Ltd. | 497,200 | $2,542,000 | 0.06% |
| Renaissance Technologies | 12,944 | $66,000 | 0.00% |
| DEUTSCHE BANK AG\ | 12,724 | $65,000 | 0.00% |